Hypokalemic periodic paralysis as an atypical presentation of primary hyperparathyroidism: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20262804Keywords:
Hypokalemia, Parathyroid adenoma, AV block, Distal RTA, Hypokalemic periodic paralysisAbstract
Excess production of parathyroid hormone from a parathyroid adenoma or hyperplasia or carcinoma can lead to hypercalcemia. It produces a wide range of clinical manifestations ranging from abdominal pain to renal calculi. Other electrolyte abnormalities such as hypomagnesemia and hypokalemia are also seen. Complications due to hypokalemia primarily involves the cardiovascular system. Hypokalemic periodic paralysis is an unusual presentation of primary hyperparathyroidism. It presents with acute onset episodes of flaccid paralysis which usually improves following potassium supplementation. We report the case of a 37-year-old male presenting with acute weakness of the extremities with laboratory investigations suggestive of hypercalcemia, hypokalemia, normal anion gaps metabolic acidosis and alkaline urine suggestive of renal tubular acidosis. On further evaluation, the patient was identified to have a right parathyroid adenoma which was managed through surgical excision. Evaluation of secondary endocrine disorders that can lead to hypokalemia is important for early recognition and appropriate management.
Metrics
References
Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018;391(10116):168-78. DOI: https://doi.org/10.1016/S0140-6736(17)31430-7
Aqeel F, Del Castillo J, Jaar BG, Hanouneh M. Hypercalcemia, Acute Kidney Injury, and Metabolic Alkalosis. Case Rep Nephrol. 2022;2022:1320259. DOI: https://doi.org/10.1155/2022/1320259
Hussain ZS, Chandru RK. Hypokalemic periodic paralysis: an unusual presentation of primary hyperparathyroidism. Int Surg J. 2018;5(6):2371-4. DOI: https://doi.org/10.18203/2349-2902.isj20182257
Soule BR, Simone NL. Hypokalemic Periodic Paralysis: a case report and review of the literature. Cases J. 2008;1(1):256. DOI: https://doi.org/10.1186/1757-1626-1-256
Paydas S, Gergerli MA, Celik A. Hypokalemic periodic paralysis, a rare yet critical condition: A case report. Med Int (Lond). 2025;5(2):21. DOI: https://doi.org/10.3892/mi.2025.220
Lo TE, Tan IT. Distal renal tubular acidosis in primary hyperparathyroidism. BMJ Case Rep. 2015;2015:bcr2014208120. DOI: https://doi.org/10.1136/bcr-2014-208120
Hati A, Chakraborty U, Chandra A, Biswas P. Hypokalaemia with Guillain-Barré syndrome: a diagnostic and therapeutic challenge. BMJ Case Rep. 2022;15(6):e249473. DOI: https://doi.org/10.1136/bcr-2022-249473
Gadalla K, Anastasopoulou C. Hypokalemic Periodic Paralysis. 2025. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026.
Kubota T, Takahashi S, Yamamoto R, Sato R, Miyanooto A, Yamamoto R, et al. Optical measurement of gating pore currents in hypokalemic periodic paralysis model cells. Dis Model Mech. 2023;16(6):dmm049704. DOI: https://doi.org/10.1242/dmm.049704
Sansone VA, Burge J, McDermott MP, Smith PC, Herr B, Tawil R, et al; Muscle Study Group. Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology. 2016;86(15):1408-16. DOI: https://doi.org/10.1212/WNL.0000000000002416
Matthews E, Portaro S, Ke Q, Sud R, Haworth A, Davis MB, et al. Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype. Neurology. 2011;77(22):1960-4. DOI: https://doi.org/10.1212/WNL.0b013e31823a0cb6